Max Robotics — Global Service Robot Directory + US Certification

About

Sonya Brin is a leading gynecologic oncologist whose work has fundamentally shaped the integration of robotic surgery into the management of gynecologic cancers. Her research focuses on optimizing surgical precision, improving patient outcomes, and systematically evaluating the clinical and operational impact of minimally invasive techniques. Brin’s landmark prospective study on sentinel lymph node detection via intra-operative cervical injection for endometrial cancer (82 citations) established a critical standard for accurate staging, reducing the morbidity of full lymphadenectomy. She also pioneered the first randomized controlled trial validating a virtual reality robotic surgery simulation curriculum for teaching robotic suturing (52 citations), directly addressing a key barrier to surgical training. Her investigations into the relationship between body mass index and robotic surgery outcomes (50 citations) and vaginal vault dehiscence after robotic hysterectomy (48 citations) have provided essential safety data for patient selection and post-operative care. More recently, Brin has explored the role of robotic surgery after neoadjuvant chemotherapy for ovarian cancer (43 citations), expanding the boundaries of what is surgically achievable. Through her three-pronged evaluation framework—encompassing clinical outcomes, patient-reported experiences, and resource utilization—Brin has offered a comprehensive model for assessing surgical innovation, making her a pivotal figure in evidence-based robotic gynecologic oncology.